Nature has added an “editor’s note” to a high-profile August paper alerting readers to the fact that the article has been subject to criticism. Journals often flag papers that are being debated — what’s unusual here is that the journal doesn’t label the notice as an official “Expression of Concern,” which are indexed by PubMed. … Continue reading Nature adds alert to heavily debated paper about gene editing
The week at Retraction Watch featured a post on just how much an authorship costs if you want to buy one, anger over charges to use a common research tool, and the revocation of a PhD from a once-rising star scientist. Here’s what was happening elsewhere:
The week at Retraction Watch featured a battle over psychologists and torture, a case of misconduct at Harvard, allegations of bribery, and a lawsuit against the New York Times. Here’s what was happening elsewhere:
The week at Retraction Watch featured the retraction of a 35-year-old paper written by a cat, and the retraction of a study about a controversial gene editing technique. Here’s what was happening elsewhere:
The week at Retraction Watch featured an update on a Harvard lab whose PI is subject to a restraining order by one of his grad students, and the retraction of a paper that used male-only pronouns. Here’s what was happening elsewhere:
A journal is investigating research by a group in Australia, after receiving “serious allegations” regarding a 2017 paper about treating eye burns. The journal, Frontiers in Pharmacology, has issued an expression of concern (EOC) for the 2017 paper while it investigates. The notice does not specify the nature of the allegations. Meanwhile, several other papers … Continue reading Work by group at Australian university faces scrutiny
Did you miss some of this week’s posts? Here they all are, in one handy roundup:
The executive board of the Leibniz Association in Germany has reprimanded the director of its institute on aging for “grossly negligent scientific misconduct.” Besides a written reprimand, the executive board has removed Karl Lenhard Rudolph’s “passive voting rights” in association committees, and excluded the institute under his leadership from receiving funds from a multi-million Euro internal … Continue reading German institute sanctions director after finding him guilty of misconduct
In the fall of 2015, out-of-work stem cell biologist Mavi Camarasa decided she had waited long enough. It had been three years since she and a colleague were, best they could tell, the first to successfully correct the most common cystic fibrosis mutation in stem cells derived from a patient. But her former lab director, … Continue reading Author of retracted gene editing paper alleges “bullying” by former PI
The week at Retraction Watch featured a survey of researchers in China with an alarming result, and asked whether philosophy has a plagiarism problem. Here’s what was happening elsewhere: